58 related articles for article (PubMed ID: 17239501)
1. The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge.
Pal S; Tifrea DF; Follmann F; Andersen P; de la Maza LM
Vaccine; 2017 Mar; 35(13):1705-1711. PubMed ID: 28238632
[TBL] [Abstract][Full Text] [Related]
2. Encapsulation of Recombinant MOMP in Extended-Releasing PLGA 85:15 Nanoparticles Confer Protective Immunity Against a
Sahu R; Dixit S; Verma R; Duncan SA; Smith L; Giambartolomei GH; Singh SR; Dennis VA
Front Immunol; 2021; 12():660932. PubMed ID: 33936096
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of amphipol-conjugated adjuvant with antigen, and adjuvant combinations, enhance immune protection elicited by a membrane protein-based vaccine against a mucosal challenge with Chlamydia.
Tifrea DF; Pal S; Le Bon C; Giusti F; Popot JL; Cocco MJ; Zoonens M; de la Maza LM
Vaccine; 2018 Oct; 36(45):6640-6649. PubMed ID: 30293763
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.
Tifrea DF; Ralli-Jain P; Pal S; de la Maza LM
Infect Immun; 2013 May; 81(5):1741-50. PubMed ID: 23478318
[TBL] [Abstract][Full Text] [Related]
5. Computational modeling of TC0583 as a putative component of the Chlamydia muridarum V-type ATP synthase complex and assessment of its protective capabilities as a vaccine antigen.
Tifrea DF; Barta ML; Pal S; Hefty PS; de la Maza LM
Microbes Infect; 2016 Apr; 18(4):245-53. PubMed ID: 26706820
[TBL] [Abstract][Full Text] [Related]
6. Rectal administration of a chlamydial subunit vaccine protects against genital infection and upper reproductive tract pathology in mice.
Pais R; Omosun Y; He Q; Blas-Machado U; Black C; Igietseme JU; Fujihashi K; Eko FO
PLoS One; 2017; 12(6):e0178537. PubMed ID: 28570663
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts.
Asquith KL; Horvat JC; Kaiko GE; Carey AJ; Beagley KW; Hansbro PM; Foster PS
PLoS Pathog; 2011 May; 7(5):e1001339. PubMed ID: 21573182
[TBL] [Abstract][Full Text] [Related]
8. Cellular Basis for the Enhanced Efficacy of the Fms-Like Tyrosine Kinase 3 Ligand (FL) Adjuvanted VCG-Based
Richardson S; Medhavi F; Tanner T; Lundy S; Omosun Y; Igietseme JU; Carroll D; Eko FO
Front Immunol; 2021; 12():698737. PubMed ID: 34249004
[TBL] [Abstract][Full Text] [Related]
9. Protective Anti-Chlamydial Vaccine Regimen-Induced CD4+ T cell Response Mediates Early Inhibition of Pathogenic CD8+ T cell Response Following Genital Challenge.
Murthy AK; Wright-McAfee E; Warda K; Moy LN; Bui N; Musunuri T; Manam S; Chako CZ; Ramsey KH; Li W
Pathog Dis; 2024 Apr; ():. PubMed ID: 38684476
[TBL] [Abstract][Full Text] [Related]
10. Chlamydia muridarum induction of glandular duct dilation in mice.
Sun X; Yang Z; Zhang H; Dai J; Chen J; Tang L; Rippentrop S; Xue M; Zhong G; Wu G
Infect Immun; 2015 Jun; 83(6):2327-37. PubMed ID: 25824829
[TBL] [Abstract][Full Text] [Related]
11.
St Jean SC; Ricart Arbona RJ; Mishkin N; Monette S; Wipf JRK; Henderson KS; Cheleuitte-Nieves C; Lipman NS; Carrasco SE
Vet Pathol; 2024 Jan; 61(1):145-156. PubMed ID: 37434451
[TBL] [Abstract][Full Text] [Related]
12. Chlamydia muridarum enters a viable but non-infectious state in amoxicillin-treated BALB/c mice.
Phillips Campbell R; Kintner J; Whittimore J; Schoborg RV
Microbes Infect; 2012 Nov; 14(13):1177-85. PubMed ID: 22943883
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of matrix metalloproteinases protects mice from ascending infection and chronic disease manifestations resulting from urogenital Chlamydia muridarum infection.
Imtiaz MT; Schripsema JH; Sigar IM; Kasimos JN; Ramsey KH
Infect Immun; 2006 Oct; 74(10):5513-21. PubMed ID: 16988226
[TBL] [Abstract][Full Text] [Related]
14. Protective antigens against glanders identified by expression library immunization.
Whitlock GC; Robida MD; Judy BM; Qazi O; Brown KA; Deeraksa A; Taylor K; Massey S; Loskutov A; Borovkov AY; Brown K; Cano JA; Torres AG; Estes DM; Sykes KF
Front Microbiol; 2011; 2():227. PubMed ID: 22125550
[TBL] [Abstract][Full Text] [Related]
15. Benzylidene acylhydrazides inhibit chlamydial growth in a type III secretion- and iron chelation-independent manner.
Bao X; Gylfe A; Sturdevant GL; Gong Z; Xu S; Caldwell HD; Elofsson M; Fan H
J Bacteriol; 2014 Aug; 196(16):2989-3001. PubMed ID: 24914180
[TBL] [Abstract][Full Text] [Related]
16. Proteomic identification of immunodominant chlamydial antigens in a mouse model.
Teng A; Cruz-Fisher MI; Cheng C; Pal S; Sun G; Ralli-Jain P; Molina DM; Felgner PL; Liang X; de la Maza LM
J Proteomics; 2012 Dec; 77():176-86. PubMed ID: 22959960
[TBL] [Abstract][Full Text] [Related]
17. Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.
Farris CM; Morrison RP
Infect Immun; 2011 Mar; 79(3):986-96. PubMed ID: 21078844
[TBL] [Abstract][Full Text] [Related]
18. Identification of immunodominant antigens by probing a whole Chlamydia trachomatis open reading frame proteome microarray using sera from immunized mice.
Cruz-Fisher MI; Cheng C; Sun G; Pal S; Teng A; Molina DM; Kayala MA; Vigil A; Baldi P; Felgner PL; Liang X; de la Maza LM
Infect Immun; 2011 Jan; 79(1):246-57. PubMed ID: 20956570
[TBL] [Abstract][Full Text] [Related]
19. Expression library immunization confers partial protection against Chlamydia muridarum genital infection.
McNeilly CL; Beagley KW; Moore RJ; Haring V; Timms P; Hafner LM
Vaccine; 2007 Mar; 25(14):2643-55. PubMed ID: 17239501
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
